Saturday, 21 September 2019

BioTech News

  • Japan Minister: Dont be afraid of new science strategy

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

  • 3SBio to merge with Decade Sunshine

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    Singapore: China-based 3SBio entered into an agreement and plan-of-merger with Decade Sunshine, an exempted company with limited liability incorporated under the laws of the Cayman Islands...Read more

  • New Bio Accelerator boosts start-ups in Bangalore, Singapore

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2014

    Singapore: In recent years Bangalore has emerged as one of the region's hottest destinations for budding entrepreneurs who have set up more than 5000 companies in the last three years. Esca...Read more

  • R&D expenditure touches $6 bn in Singapore

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

    Singapore: Singapore's gross expenditure on R&D (GERD) recorded a new high of $6 billion (S$7.4 billion) in 2011, according to the National Survey of R&D, 2011, produced by the Agen...Read more

  • Eisai signs agreement with Epizyme and Roche

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Eisai has signed an agreement with Epizyme and Roche Molecular Systems to collaborate on the development of a companion diagnostic to help Eisai and Epizyme identify patients fo...Read more

  • VeriStem wins BioSpectrum award for stem cell technology

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriStem Technologies of Singapore aims to fulfil this industry need. The c...Read more

  • Starpharma's VP becomes CEO of Viralytics

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Starpharma's vice president, Dr Malcolm McColl, has been appointed CEO, Viralytics. Prior to this, Dr McColl was VP, business development, Starpharma, since 2010. He has worked...Read more

  • Bluechiip, Gentris sign cryogenic sample management deal

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Bluechiip, which has developed a unique temperature sensing and tracking solution initially for cryogenic sample management in the healthcare and life science industry, signed a...Read more

  • Life Technologies inks supply deal with Novartis

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Life Technologies has signed a long-term supply and exclusive licensing agreement with Novartis for immunotherapeutics involving T cells modified to express chimeric antigen rece...Read more

  • Sanofi appoints Dr Gary Nabel as chief scientific officer

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Sanofi appointed Dr Gary J Nabel as the senior vice president, chief scientific officer and deputy to the president for Global R&D, effective December 3, 2012. Dr Nabel will...Read more

  • BSI Awards Gallery - Testing

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2014

    Please visit this space for further updates.....Read more

  • Stanford Univ, DBT India program is a big hit'

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Dr Rajiv Doshi, executive director (US), Stanford-India Biodesign (SIB), and consulting assistant professor, Stanford University, US, was one of the many eminent individuals who attended th...Read more

  • Study compares efficacy of oral, injectable polio vaccines

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

    Singapore: NanoPass Technologies, a pioneer in intradermal vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phas...Read more

  • Has collaborative commercialization arrived in India?

    BioTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Faced with many uncertainties after the introduction of a series of reforms from the 1990s, both Indian and foreign firms have closely followed the growth of the pharmaceutical industry. Lo...Read more

  • A time to rethink talent management

    BioTech |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • Merck announces Q2 2012 Results

    BioTech |  Company results | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2012

    Singapore: Merck, known as MSD outside the US and Canada, today announced financial results for the second quarter (Q2) of 2012. While the second quarter non-GAAP EPS increased 11 percent o...Read more

  • Melanoma study reaches efficacy milestone

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

    Singapore: Australia-based Viralytics in its ongoing US-based phase II melanoma trial of its virotherapy candidate Cavatak achieved an interim efficacy milestone of three Objective Respons...Read more

  • Innovative way to meet the global HSA requirement

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

    Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around the world. The primary source of the HSA is donated human blood, whic...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls